KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Receivables - Net: 2018-2025

Historic Receivables - Net for BioNTech SE (BNTX) over the last 6 years, with Sep 2025 value amounting to $807.6 million.

  • BioNTech SE's Receivables - Net fell 25.57% to $807.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $807.6 million, marking a year-over-year decrease of 25.57%. This contributed to the annual value of $1.6 billion for FY2024, which is 32.56% down from last year.
  • Per BioNTech SE's latest filing, its Receivables - Net stood at $807.6 million for Q3 2025, which was down 47.86% from $1.5 billion recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Receivables - Net registered a high of $14.2 billion during Q1 2022, and its lowest value of $81.6 million during Q2 2024.
  • For the 3-year period, BioNTech SE's Receivables - Net averaged around $2.0 billion, with its median value being $1.6 billion (2024).
  • Its Receivables - Net has fluctuated over the past 5 years, first spiked by 149,211.93% in 2021, then plummeted by 97.18% in 2024.
  • Over the past 5 years, BioNTech SE's Receivables - Net (Quarterly) stood at $14.2 billion in 2021, then tumbled by 48.53% to $7.3 billion in 2022, then plummeted by 68.18% to $2.3 billion in 2023, then plummeted by 32.56% to $1.6 billion in 2024, then decreased by 25.57% to $807.6 million in 2025.
  • Its Receivables - Net stands at $807.6 million for Q3 2025, versus $1.5 billion for Q2 2025 and $1.0 billion for Q1 2025.